Evidence map›Paper›PMID 42796535›Full record

ArticleMolecules (Basel, Switzerland)2026

Nanoconfinement-Enhanced CO

Konstantin Belov, Maria Ikim, Varvara Demina, Valentina Sobornova, Maria Mochalova, Natalia Menshutina, Michael Kiselev, Leonid Trakhtenberg, Ilya Khodov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Konstantin BelovG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, Ivanovo 153045, Russia.ORCID 0000-0001-5690-340X
Maria IkimN.N. Semenov Federal Research Center for Chemical Physics RAS, Moscow 119991, Russia.
Varvara DeminaN.N. Semenov Federal Research Center for Chemical Physics RAS, Moscow 119991, Russia.
Valentina SobornovaG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, Ivanovo 153045, Russia.ORCID 0000-0001-9505-0518
Maria MochalovaDepartment of Chemical and Pharmaceutical Engineering, D. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia.
Natalia MenshutinaDepartment of Chemical and Pharmaceutical Engineering, D. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia.ORCID 0000-0001-7806-1426
Michael KiselevG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, Ivanovo 153045, Russia.
Leonid TrakhtenbergN.N. Semenov Federal Research Center for Chemical Physics RAS, Moscow 119991, Russia.
Ilya KhodovG.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, Ivanovo 153045, Russia.ORCID 0000-0003-2439-9290

Funding

Russian Science Foundation 22-13-00257-Π
6 · The paper itself

Abstract

The interaction between carbon dioxide and molecularly confined pharmaceutical compounds can result in CO

Indexed as

aerogelsBET analysiscarbon dioxideflufenamic acidmefenamic acidtemperature-programmed desorption/oxidation

Identifiers

PMID42796535
PMCPMC13609461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.